Back to home

ROCK2 Inhibitor

Hematology, Chronic Graft Versus, ROCK2 Inhibitor, JAK1 - JAK2 Inhibitor, Issue3

Recent Updates in the Treatment of Chronic-Graft-Versus-Host Disease

Fatima Khan, PharmD & Ila M. Saunders, PharmD, BCOP Fatima Khan, PharmD & Ila M. Saunders, PharmD, BCOP

Chronic graft-versus-host disease (cGVHD) is one of most common, yet severe, consequences of allogeneic hematopoietic stem cell transplantation. Occurring in up to 70% of patients, cGVHD is the leading cause of non-relapse mortality after allogeneic transplantation. Two new agents, belumosudil ...

Read more